Prostate Cancer Coverage from Every Angle

Sandy Srinivas, MD, on Balancing Quality of Life and Survival When Making Decisions About Prostate Cancer Treatment

Posted: Friday, March 19, 2021

Sandy Srinivas, MD, of Stanford Cancer Institute, talks about working with patients who have metastatic castration-resistant prostate cancer to individualize their treatment and help them weigh efficacy, toxicity, and cost.

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.